Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Anticancer Research|September 4, 2020
YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin ExpressionTakeshi Miyao, Hidekazu Koike, Yoshitaka Sekine, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 22, 2020
[USEFULNESS OF VIVID (VISUALIZATION OF VARIOUS INTEGRATION WITH DIFFUSION) ON COGNITIVE FUSION PROSTATE BIOPSY]Akira Ohtsu, Nobuaki Shimizu, Hiroyuki Horikoshi, et al.Journal of Ovarian Research|December 8, 2025
Pan-cancer profiling links C1orf50 to DNA repair and immune modulation in ovarian cancerAnna Rogachevskaya, Yusuke Otani, Akira Ohtsu, et al.International Journal of Clinical Oncology|March 8, 2026
Comparative genomic landscape of primary and metastatic bladder urothelial carcinoma in a large-scale cohortAkira Ohtsu, Yusuke Otani, Seiji Arai, et al.IJU Case Reports|January 6, 2023
Two cases of CRPC with <i>BRCA</i> mutation treated by olaparib after favorable response to cisplatinYoshiyuki Miyazawa, Takanori Shimizu, Yoshitaka Sekine, et al.IJU Case Reports|January 3, 2025
Afebrile tuberculous prostatic abscess with rectal fistula after intravesical Bacillus Calmette-Guérin immunotherapyTatsuhiro Sawada, Ayaka Igarashi, Seiji Arai, et al.IJU Case Reports|December 23, 2025
Computed Tomography-Guided Biopsy of a Ureteral Urothelial Carcinoma Mimicking a Submucosal Bladder Tumor at the Ureterovesical JunctionAkira Ohtsu, Yuji Fujizuka, Seiji Arai, et al.IJU Case Reports|November 4, 2025
Intermittent Recurrence of Ureterosciatic Hernia After Spontaneous Resolution, Complicated by Emphysematous PyelonephritisAkira Ohtsu, Keisuke Hori, Seiji Arai, et al.BMC Cancer|March 22, 2025
The combination of poly(ADP-ribose) polymerase inhibitor and statin inhibits the proliferation of human castration-resistant and taxane-resistant prostate cancer cells in vitro and in vivoYoshitaka Sekine, Daisuke Oka, Akira Ohtsu, et al.Biochemical and Biophysical Research Communications|September 9, 2022
Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cellsAkira Ohtsu, Seiji Arai, Tatsuhiro Sawada, et al.Pageof 2